Lisa Phillips is an experienced Healthcare M&A Expert, B2B writer, research analyst, and journalist. She joined Irving Levin Associates in December 2012 as Editor of The Health Care Information Source and all its companion products, the weekly Health Care Deal News, the monthly Health Care M&A News, the quarterly Health Care M&A Report and annual Health Care Services Acquisition Report.
Lisa has more than 25 years of reporting, writing and researching content for trade publications such as Advertising Age, American Demographics, The American Lawyer and Folio:. She helped to launch a new line of business research at Gartner, Inc., as Editorial Director of GartnerG2. Her previous position was as a Senior Analyst at eMarketer, Inc.
Read Full Bio
The U.S. hospital system has had a stress-filled year, to say the least. By mid-December 2020, the nation’s death toll from the coronavirus topped 300,000 and daily hospitalizations closed in on 11,000. Front-line healthcare workers began receiving the... Read More »
Like most other healthcare sectors, the Physician Medical Group market was hit hard when the coronavirus pandemic arrived in March 2020. Deal activity across the board came to a sudden halt in mid-March, except for deals that were far along in the sales process.... Read More »
Hospitals are the subject of intense national attention this year, thanks to the coronavirus pandemic. When Covid-19 hit hard in March, several hospitals and health systems were overwhelmed with critically ill patients. Elective surgeries were canceled, emergency room... Read More »
Four years after acquiring CarePort Health, healthcare IT company Allscripts Healthcare Solutions Ltd. (NASDAQ: MDRX) is selling the post-acute patient care business to WellSky Corp. for $1.35 billion. Allscripts announced its acquisition of CarePort on October 20,... Read More »
It’s been a busy year for Bristol Myers Squibb (NYSE: BMY) and its bankers. After two deals announced in 2020, the pharma giant is back for more with a $13.1 billion cash offer ($225 per share) for MyoKardia, Inc. (NASDAQ: MYOK). MyoKardia is a clinical-stage... Read More »